Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-24 4:11 pm Purchase | 2026-03-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 37,821,797 7.200% | 14,385,161 (+61.38%) | Filing History |
| 2026-03-27 11:36 am Sale | 2026-03-13 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 0 0.000% | -24,272,798 (Position Closed) | Filing History |
| 2026-02-05 10:04 am Sale | 2025-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 23,774,972 4.600% | -1,089,086 (-4.38%) | Filing History |
| 2026-02-03 11:38 am Purchase | 2025-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 37,316,856 7.250% | 4,970,459 (+15.37%) | Filing History |
| 2025-12-23 7:25 pm Sale | 2024-11-20 | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 7,062,869 1.400% | -4,229,068 (-37.45%) | Filing History |
| 2025-02-14 6:41 pm Sale | 2024-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | RA CAPITAL MANAGEMENT L.P. | 7,725,096 2.000% | -7,659,519 (-49.79%) | Filing History |
| 2025-02-14 11:23 am Purchase | 2024-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 32,346,397 8.470% | 9,270,345 (+40.17%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 24,864,058 6.500% | 11,706,364 (+88.97%) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 23,436,636 6.100% | 2,693,839 (+12.99%) | Filing History |
| 2024-11-12 4:57 pm Unchanged | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 24,272,798 8.820% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | RECURSION PHARMACEUTICALS INC RXRX | FMR LLC | 8,363,529 3.040% | -2,533,757 (-23.25%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 20,742,797 7.500% | 0 (Unchanged) | Filing History |
| 2024-11-04 4:16 pm Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | KINNEVIK AB (PUBL) | 11,905,668 4.300% | 1,500,000 (+14.42%) | Filing History |
| 2024-11-04 1:27 pm Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 24,272,798 8.820% | 8,607,588 (+54.95%) | Filing History |
| 2024-11-04 09:46 am Purchase | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 25,239,870 9.200% | 18,698,991 (+285.88%) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 20,742,797 7.500% | 8,348,925 (+67.36%) | Filing History |
| 2024-10-18 10:59 am Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | STATE STREET CORP STT | 12,870,272 4.700% | 718,626 (+5.91%) | Filing History |
| 2024-07-08 4:17 pm Purchase | 2024-06-28 | 13G | RECURSION PHARMACEUTICALS INC RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.900% | 15,384,615 (New Position) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 15,665,210 7.520% | 5,607,847 (+55.76%) | Filing History |
| 2024-02-12 12:21 pm Purchase | 2024-01-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 23,076,052 11.080% | 2,421,765 (+11.73%) | Filing History |